Anti-mouse CD8α-InVivo

目录号：A2102         批次号: A210217

       克隆号：2.43

打印

Anti-mouse CD8α(克隆号：2.43)可与小鼠CD8α结合反应。CD8是一种穿膜糖蛋白，是T细胞受体（TCR）的协同受体。有助于后续与抗原呈递细胞的交流通讯。

抗体信息

克隆号 2.43
免疫原 Mouse CTL clone L3
配制 PBS buffer, pH 7.0
推荐同型对照 Rat IgG2b, κ
应用 In vivo CD8+ T cell depletion,WB
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 6.07 mg/mL
内毒素 ＜1 EU/mg

客户使用selleck产品的实验数据

Anti-mouse CD8α-InVivo在文献中得到引用

cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation [ Sci Immunol, 2024, 9(98):eadk2612] PubMed: 39093956
Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity [ Cell Rep Med, 2024, 5(5):101533] PubMed: 38744278
Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade [ J Immunother Cancer, 2024, 12(9)e009327] PubMed: 39244215
Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer [ Cancer Lett, 2024, 589:216836.] PubMed: 38556105
Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment [ Cell Rep, 2024, 43(9):114697] PubMed: 39217611
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function [ Cell Oncol (Dordr), 2024, 10.1007/s13402-024-00959-1] PubMed: 38809326
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709] PubMed: 38001101
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709.] PubMed: 38001101
Enhanced Chemo-Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer [ Adv Sci (Weinh), 2023, 10(35):e2303819] PubMed: 37875399
Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity [ Cell Rep Med, 2023, 4(12):101303] PubMed: 38029750

禁止用于人体及治疗！